{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:36:34Z","timestamp":1790015794671,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.clon.2006.06.011","type":"journal-article","created":{"date-parts":[[2006,7,22]],"date-time":"2006-07-22T07:17:05Z","timestamp":1153552625000},"page":"710-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Magnesium Depletion in Patients Receiving Cisplatin-based Chemotherapy"],"prefix":"10.1016","volume":"18","author":[{"given":"E.","family":"Hodgkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.L.","family":"Neville-Webbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2006.06.011_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-90-6-929","article-title":"Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin","volume":"90","author":"Schilsky","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clon.2006.06.011_bib2","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/1097-0142(19851215)56:12<2765::AID-CNCR2820561208>3.0.CO;2-2","article-title":"Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin","volume":"56","author":"Vogelzang","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2006.06.011_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0090-8258(88)90052-2","article-title":"Cisplatin-induced hypomagnesemia with seizures: a case report and review of the literature","volume":"30","author":"Bellin","year":"1988","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib4","first-page":"1767","article-title":"Persistent hypomagnesaemia following cisplatin chemotherapy for testicular cancer","volume":"66","author":"Schilsky","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.clon.2006.06.011_bib5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/0003-4819-95-5-628","article-title":"Renal and electrolyte disturbances associated with cisplatin","volume":"95","author":"Blachley","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clon.2006.06.011_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00694330","article-title":"Cisplatin nephrotoxicity","volume":"25","author":"Daugaard","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2 suppl 7","key":"10.1016\/j.clon.2006.06.011_bib7","first-page":"72","article-title":"Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects","volume":"26","author":"Capizzi","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib8","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/1097-0142(19820501)49:9<1784::AID-CNCR2820490909>3.0.CO;2-6","article-title":"Acute nephrotoxicity following cis-dichlorodiammine-platinum","volume":"49","author":"Bitran","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2006.06.011_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0277-5379(85)90127-0","article-title":"Cis-diamminedichloroplatinum-induced hypomagnesemia and renal magnesium wasting","volume":"21","author":"Bell","year":"1985","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0272-6386(86)80020-8","article-title":"Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin","volume":"8","author":"Lam","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clon.2006.06.011_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0002-9343(82)90519-8","article-title":"Disorders of calcium and magnesium homeostasis","volume":"72","author":"Agus","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.clon.2006.06.011_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/ctrv.1999.0097","article-title":"Cisplatin and hypomagnesaemia","volume":"25","author":"Lager","year":"1999","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clon.2006.06.011_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0002-9378(85)80255-6","article-title":"Magnesium homeostasis following chemotherapy with cisplatin: a prospective study","volume":"153","author":"Stewart","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clon.2006.06.011_bib14","first-page":"547","article-title":"Tetany: a complication of cis-dichlorodiammineplatinum (II) therapy","volume":"63","author":"Hayes","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.clon.2006.06.011_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/bjc.1990.429","article-title":"A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia","volume":"62","author":"Vokes","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2006.06.011_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-100-5-704","article-title":"Cisplatin","volume":"100","author":"Loehrer","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clon.2006.06.011_bib17","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/archinte.1984.00350220063013","article-title":"Hypomagnesemia after cisplatin combination chemotherapy","volume":"144","author":"Buckley","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clon.2006.06.011_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(97)10535-9","article-title":"Magnesium and phosphorus","volume":"352","author":"Weisinger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2006.06.011_bib19","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1200\/JCO.1996.14.11.2923","article-title":"Evaluation of long-term toxicity after chemotherapy for testicular cancer","volume":"14","author":"Bokemeyer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00000421-199208000-00016","article-title":"Intravenous and oral magnesium supplementations in the prophylaxis of cisplatin-induced hypomagnesemia","volume":"15","author":"Martin","year":"1992","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0272-6386(12)80667-6","article-title":"Magnesium deficiency: pathophysiologic and clinical overview","volume":"24","author":"Al-Ghamdi","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clon.2006.06.011_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00257749","article-title":"Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapy","volume":"9","author":"Macaulay","year":"1982","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clon.2006.06.011_bib23","first-page":"521","article-title":"Renal toxicities of chemotherapy","volume":"19","author":"Patterson","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00253068","article-title":"Cumulative renal tubular damage associated with cisplatin nephrotoxicity","volume":"18","author":"Goren","year":"1986","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clon.2006.06.011_bib25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000227185","article-title":"Changes in intracellular magnesium concentrations during cisplatin chemotherapy","volume":"50","author":"Sartori","year":"1993","journal-title":"Oncology"},{"key":"10.1016\/j.clon.2006.06.011_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0959-8049(94)00420-A","article-title":"A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil","volume":"31A","author":"Evans","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2006.06.011_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-91-3-502_2","article-title":"Cisplatin and renal magnesium wasting","volume":"91","author":"Winkler","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clon.2006.06.011_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/bjc.1986.147","article-title":"Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial","volume":"54","author":"Willox","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2006.06.011_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/cs0750203","article-title":"Renal magnesium wasting and hypocalciuria in chronic cis-platinum nephropathy in man","volume":"75","author":"Mavichak","year":"1988","journal-title":"Clin Sci"},{"key":"10.1016\/j.clon.2006.06.011_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00857658","article-title":"Chronic renal magnesium loss, hypocalciuria and mild hypokalaemic metabolic alkalosis after cisplatin","volume":"4","author":"Bianchetti","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clon.2006.06.011_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000168288","article-title":"Persisting renotubular sequelae after cisplatin in children and adolescents","volume":"11","author":"Bianchetti","year":"1991","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clon.2006.06.011_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U","article-title":"Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis","volume":"28","author":"Ariceta","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-8258(83)90156-7","article-title":"Cis-Platinum-induced hypomagnesaemia and peripheral neuropathy","volume":"16","author":"Ashraf","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib34","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1001\/archinte.1984.00350220052010","article-title":"Hypomagnesemia associated with cisplatin combination chemotherapy","volume":"144","author":"Flombaum","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clon.2006.06.011_bib35","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archinte.1981.00340080136031","article-title":"Cisplatin-induced hypomagnesemic hypocalcaemia","volume":"141","author":"Hill","year":"1981","journal-title":"Arch Intern Med"},{"issue":"8207","key":"10.1016\/j.clon.2006.06.011_bib36","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(80)92367-3","article-title":"Tetany associated with cis-platin","volume":"2","author":"Stuart-Harris","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2006.06.011_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/oxfordjournals.annonc.a057776","article-title":"Intravenous magnesium supplementation during cisdiammine-dichloroplatinum administration prevents hypomagnesaemia","volume":"1","author":"Netten","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib38","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1097-0142(19831201)52:11<2025::AID-CNCR2820521109>3.0.CO;2-O","article-title":"Effective chemotherapy for advanced carcinoma of the cervix with bleomycin, cisplatin, vincristine and methotrexate","volume":"52","author":"Rosenthal","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2006.06.011_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08880018809031245","article-title":"Prevention of cisplatin-induced hypomagnesemia","volume":"5","author":"Kibirige","year":"1988","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib40","first-page":"123","article-title":"Changes in serum, erythrocyte, and urinary magnesium after a single dose of cisplatin combination chemotherapy","volume":"4","author":"Abbasciano","year":"1991","journal-title":"Magnes Res"},{"key":"10.1016\/j.clon.2006.06.011_bib41","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/bjc.1998.276","article-title":"Cisplatin dose rate as a risk factor for nephrotoxicity in children","volume":"77","author":"Skinner","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2006.06.011_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF01613129","article-title":"Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer","volume":"117","author":"Markman","year":"1991","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clon.2006.06.011_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000227478","article-title":"Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer","volume":"52","author":"Fossa","year":"1995","journal-title":"Oncology"},{"key":"10.1016\/j.clon.2006.06.011_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s004670050507","article-title":"Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma","volume":"12","author":"Nogueira","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clon.2006.06.011_bib45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0959-8049(95)00599-4","article-title":"Magnesium supplements with cisplatin chemotherapy","volume":"32A","author":"Lofts","year":"1996","journal-title":"Eur J Cancer"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655506002251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655506002251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:31:41Z","timestamp":1760542301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655506002251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0936655506002251"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2006.06.011","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnesium Depletion in Patients Receiving Cisplatin-based Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2006.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}